Phase
Condition
Smallpox
Treatment
Typhoid VI Polysaccharide Vaccine Injectable Solution
Bavarian Nordic smallpox vaccine
Clinical Study ID
Ages > 2 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Household member of person with laboratory confirmed mpox
Age ≥ 2 years
Within 14 days of onset of illness in mpox index case
Exclusion
Exclusion Criteria:
Pregnancy
Breastfeeding
Past serious allergic reaction to study vaccine components
Previous smallpox vaccination
Current or planned use of another investigational drug at any point during studyparticipation
Study Design
Study Description
Connect with a study center
Catholic University of Bukavu
Kinshasa, Bukavu
Congo, The Democratic Republic of theActive - Recruiting
Federal Medical Center
Abuja,
NigeriaSite Not Available
University of Abuja Teaching Hospital
Abuja,
NigeriaSite Not Available
University of Ibadan
Ibadan,
NigeriaSite Not Available
Irrua Specialist Teaching Hospital
Irrua,
NigeriaSite Not Available
Aminu Kano Teaching Hospital
Kano,
NigeriaSite Not Available
Lagos University Teaching Hospital
Lagos,
NigeriaSite Not Available
Niger Delta Teaching Hospital
Okolobiri,
NigeriaSite Not Available
University of Port Harcourt Teaching Hospital
Port Harcourt,
NigeriaSite Not Available
Makerere University Lung Institute
Kampala,
UgandaSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.